Co-Diagnostics Executive Compensation Revealed

Ticker: CODX · Form: DEF 14A · Filed: Apr 14, 2025 · CIK: 1692415

Co-Diagnostics, Inc. DEF 14A Filing Summary
FieldDetail
CompanyCo-Diagnostics, Inc. (CODX)
Form TypeDEF 14A
Filed DateApr 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: executive-compensation, DEF14A, disclosure

Related Tickers: CODX

TL;DR

CODX proxy statement out, detailing exec pay for 2024. Check the numbers.

AI Summary

Co-Diagnostics, Inc. filed its DEF 14A on April 14, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on compensation for both PEO (Principal Executive Officer) and Non-PEO members, specifically referencing adjustments for grant date values and year-end fair values of unvested awards. The company is based in Salt Lake City, UT.

Why It Matters

This filing provides transparency into how Co-Diagnostics compensates its top executives, which can influence investor perception and employee morale.

Risk Assessment

Risk Level: medium — DEF 14A filings are routine disclosures, but the details within can reveal compensation trends or potential issues that may impact stock price.

Key Numbers

  • 2024-12-31 — Fiscal Year End (The period for which executive compensation is reported.)
  • 20250414 — Filing Date (The date Co-Diagnostics, Inc. filed this DEF 14A.)

Key Players & Entities

  • Co-Diagnostics, Inc. (company) — Filer of the DEF 14A
  • 4049 SOUTH HIGHLAND DRIVE (location) — Company's business and mailing address
  • SALT LAKE CITY (location) — Company's city
  • UT (location) — Company's state
  • 8012789769 (phone_number) — Company's business phone number

FAQ

What specific compensation elements are detailed for PEO members in 2024?

The filing references 'AdjustmentForGrantDateValuesInTheSummaryCompensationTableMember' and 'YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember' for PEO members for the 2024 fiscal year.

What is the fiscal year end date for Co-Diagnostics, Inc.?

The fiscal year end date for Co-Diagnostics, Inc. is December 31, 2024.

When was this DEF 14A filing submitted?

This DEF 14A filing was submitted on April 14, 2025.

What is the SIC code for Co-Diagnostics, Inc.?

The Standard Industrial Classification (SIC) code for Co-Diagnostics, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Are compensation details provided for non-executive officers?

Yes, the filing includes compensation details for 'NonPeoNeoMember' in addition to 'PeoMember'.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 14, 2025 regarding Co-Diagnostics, Inc. (CODX).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.